Literature DB >> 10648184

Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence.

N Price1, D C Tscharke, M Hollinshead, G L Smith.   

Abstract

This paper presents a characterisation of vaccinia virus (VV) gene B7R that was predicted to encode a polypeptide of 182 amino acids with an N-terminal signal peptide. In vitro transcription and translation analysis showed the B7R gene product was a 21-kDa protein that, in the presence of microsomes, was processed into an 18-kDa mature form. The 18-kDa form associated with the microsomal membranes and was within the lumen of the vesicle where it was inaccessible to exogenous protease or an antibody raised against the B7R C terminus. Within VV-infected cells, the 18-kDa form of B7R was detected late during infection in the endoplasmic reticulum where it colocalised with protein disulphide isomerase. The B7R protein was detected neither in the culture supernatant nor associated with virus particles. A virus deletion mutant lacking the B7R gene and a revertant virus were constructed. Compared to wild-type and revertant viruses, the deletion mutant replicated normally in cell culture and had unaltered virulence in a murine intranasal model of infection. However, the deletion mutant was attenuated in a murine intradermal model where it induced a smaller lesion than the control viruses. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648184     DOI: 10.1006/viro.1999.0116

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection.

Authors:  Olivia Hinthong; Xiao-Lu Jin; Joanna L Shisler
Journal:  Virology       Date:  2008-01-10       Impact factor: 3.616

2.  Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity.

Authors:  Ariana G Bravo Cruz; Aiguo Han; Edward J Roy; Arielle B Guzmán; Rita J Miller; Elizabeth A Driskell; William D O'Brien; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

3.  Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity.

Authors:  P H Verardi; L A Jones; F H Aziz; S Ahmad; T D Yilma
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Vaccinia virus A43R gene encodes an orthopoxvirus-specific late non-virion type-1 membrane protein that is dispensable for replication but enhances intradermal lesion formation.

Authors:  Cindy L Sood; Bernard Moss
Journal:  Virology       Date:  2009-11-08       Impact factor: 3.616

5.  Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions.

Authors:  Nathan P Manes; Ryan D Estep; Heather M Mottaz; Ronald J Moore; Therese R W Clauss; Matthew E Monroe; Xiuxia Du; Joshua N Adkins; Scott W Wong; Richard D Smith
Journal:  J Proteome Res       Date:  2008-01-19       Impact factor: 4.466

Review 6.  Monkeypox virus and insights into its immunomodulatory proteins.

Authors:  Jessica R Weaver; Stuart N Isaacs
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

7.  Attenuation of monkeypox virus by deletion of genomic regions.

Authors:  Juan G Lopera; Elizabeth A Falendysz; Tonie E Rocke; Jorge E Osorio
Journal:  Virology       Date:  2014-12-01       Impact factor: 3.616

8.  Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.

Authors:  Jessamine E Hazlewood; Troy Dumenil; Thuy T Le; Andrii Slonchak; Stephen H Kazakoff; Ann-Marie Patch; Lesley-Ann Gray; Paul M Howley; Liang Liu; John D Hayball; Kexin Yan; Daniel J Rawle; Natalie A Prow; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2021-01-13       Impact factor: 6.823

9.  A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.

Authors:  Natalie A Prow; Liang Liu; Eri Nakayama; Tamara H Cooper; Kexin Yan; Preethi Eldi; Jessamine E Hazlewood; Bing Tang; Thuy T Le; Yin Xiang Setoh; Alexander A Khromykh; Jody Hobson-Peters; Kerrilyn R Diener; Paul M Howley; John D Hayball; Andreas Suhrbier
Journal:  Nat Commun       Date:  2018-03-26       Impact factor: 14.919

10.  Genome of Alaskapox Virus, A Novel Orthopoxvirus Isolated from Alaska.

Authors:  Crystal M Gigante; Jinxin Gao; Shiyuyun Tang; Andrea M McCollum; Kimberly Wilkins; Mary G Reynolds; Whitni Davidson; Joseph McLaughlin; Victoria A Olson; Yu Li
Journal:  Viruses       Date:  2019-08-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.